McDermott Will & Emery advised Oakley Capital, a leading pan-European private equity investor, on the acquisition of Flemming Dental, Excent, and Artinorway Group in a carve-out from European Dental Group, a leading pan-European oral care and services provider, to form one of the leading dental laboratories groups in Europe.
McDermott’s European, cross-border team assisted Oakley Capital in all health regulatory, medical devices, reimbursement and health data matters.
The transaction is subject to regulatory approval. More details can be found here.
The McDermott team was led by partners Deniz Tschammler, Sharon Lamb and Stephan Rau, supported by the wider European team, including partner Anne France-Moreau, counsel Jana Grieb and associates Sylvia Petereit-Kemter, Lisa Schickling, David Gibson, Katharina Hoffmeister, Michaela Novakova, Alexandra Heberle, Alice Villagrasa, Lea Hachmeister, Camille Michaud and Sebastian Gerstner.
eSight: “The technology has the potential to change someone’s life”
Microsoft invests £2.5 billion in UK AI
TMS shows promise in tackling depression ‘epidemic’
AI depression app set for NHS clinical trial
UK Biobank releases world’s largest single set of sequencing data
Listen: Longevity, Eastern wisdom and Western science
Fundamental principles of healthcare digital twins
Tackling the diagnostic testing sustainability problem
Gym-going men ‘unaware’ of protein risk to fertility
Anti-choke mug protects Parkinson’s patients
- News3 weeks ago
Why a leading healthcare CEO sees recombinant DNA as a metaphor for developing breakthrough technologies
- AI5 days ago
AI model predicts breast cancer risk without racial bias
- Medtech4 weeks ago
Surtex Instruments to unveil game-changing Infinex microsurgery instruments at MEDICA
- AI2 weeks ago
Humans make better cancer treatment decisions than AI, study finds